Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Oct 13, 2026

KYTX — Kyverna Therapeutics, Inc. Dilution Risk Tracker

Track KYTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KYTX — Get alerts when the score changes →

As of October 13, 2026, Kyverna Therapeutics, Inc. (KYTX) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Kyverna Therapeutics, Inc. has a market capitalization of $384.05M, 61.84M shares outstanding, 113 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $300.00M, ATM program capacity of $100.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
87
💰 Cash Runway
25
📊 Float Risk
50
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 19%
💰 Capital Raise model 38%
• Active shelf registration ($300M, 78% of market cap)
• Active ATM program with $100M remaining capacity
🔔 Track KYTX — Get forecast alerts →

Market Data

Market Cap$384.05M
Shares Outstanding61.84M
Float35.50M
Cash$199.43M
Debt$24.88M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding61.84MVerified float table or market cache
Public Float35.50MVerified float table or market cache
Market Cap$384.05MMarket data cache
Cash Runway19.4 monthsDilutionWatch score inputs
Shelf Capacity$300.00MSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 2, 424B5 1, EFFECT 1, S-3 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 14.3% shares (2026Q1 vs prior)
113 institutional holders · 39.45M shares
#1 GordonMD Global Investments LP 4.24M shares
#2 GILEAD SCIENCES, INC. 4.13M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.57M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest9.62M
Days to Cover8.8
% of Float27.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-26
EFFECT EFFECT 2026-04-02
424B5 ATM 2026-04-02
S-3 SHELF 2026-03-26
4 INSIDER TRANSACTION 2026-03-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual KYTX Dilution Snapshot

Kyverna Therapeutics, Inc. (KYTX) has a DilutionScore of 52/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

KYTX's DilutionScore is currently 52/100 (High risk), with 1 score change tracked over 89 days. The score improved from 51/100 (High risk).

Period Score Risk Level Duration
Jul 17 – Oct 13, 202652/100HIGH88 days
Jul 16, 202651/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

KYTX shares outstanding have increased 2.0% from 59.61M (Mar 2026) to 60.80M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 31, 202660.80M35.50M▲ 0.01%
May 21, 202660.80M35.50M▲ 0.42%
May 15, 202660.80M35.35M▲ 0.56%
Apr 22, 202660.53M35.15M▲ 0.09%
Apr 01, 202660.46M35.12M▲ 0.08%
Mar 30, 202660.46M35.09M▲ 43.98%
Mar 09, 202659.61M24.37M▼ 0.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track KYTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment KYTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking KYTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KYTX
KYTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.